Canandaigua National Bank & Trust’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,768
Closed -$216K 334
2024
Q3
$216K Buy
+3,768
New +$216K 0.02% 323

Other funds holding HALO

Canandaigua National Bank & Trust's HALO Position: Q4 2024 in Review

Canandaigua National Bank & Trust sold out of Halozyme (HALO) in Q4 2024, closing a stake of 3,768 shares — an estimated $216K sold.

Canandaigua National Bank & Trust first reported a position in HALO in Q3 2024 and held it in 1 quarter. The position peaked at $216K in Q3 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Canandaigua National Bank & Trust reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Canandaigua National Bank & Trust sold 3,768 Halozyme shares in Q4 2024, an estimated $216K.
  • Canandaigua National Bank & Trust first reported a position in Halozyme in Q3 2024 and held it in 1 quarter.
  • Canandaigua National Bank & Trust's Halozyme position peaked at $216K in Q3 2024.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Canandaigua National Bank & Trust's 13F filing for Q4 2024, filed 6 Jan 2025.